Blog

01/12/09 — 0 Comments

Harrison Hayes Creates Angel Fund to Invest in Emerging Life Science Firms

Based on our broad contacts throughout the life sciences industry, we have made the decision to put together an Angel Fund that will invest up to $250,000 per transaction in emerging life science technology companies. We will invest in firms whose technologies and products are applicable across a wide range of segments including human healthcare therapeutics and diagnostics/devices; health/wellness; agricultural biotechnology; material science and industrial biotechnology (biomaterials/bioprocesses).

We employ a flexible investment approach to working with management and vendors and aim to align interests to the benefit of all. In our deals, management will have a significant financial stake in the company.

Harrison Hayes' success is founded on building long-term relationships with entrepreneurs and portfolio companies. Over two decades of experience identifying, validating and backing emerging trends and technologies will provide our portfolio companies strategic advantages essential to success.

Please contact us at jcaldwell@harrisonhayes.com for an initial review. The further evaluation of the business proposals will be based on supporting technical materials such as an executive summary, business plan or investment memorandum.

Comments

No comments have been posted for this entry.

Post a Comment

Categories Categories

Announcements (6)

Industry News (13)

Tags Tags

EHR, consultant, pharmaceutical, HP, The Internet of Things, market innovation, harrison hayes, growth strategy, MENA, new york, Revive a Dying Brand, market opportunity, Beijing, Key Opinion Leader, arbitrage, outsource, competitive advantage, diagnostics, Volumetrics, Governments, research, five forces, VOC, Predictive, China, Middle East Northern Africa, IT, Monocle, material science, charlotte jobs, Building, volumetric research, top 5, Real Time, electronic health record, business, ideation, building a brand, IT Research, fund, out-licensing, innovation research, linkedin, ideation research, modeling, uncontested market space, therapeutics, in-licensing, branding, bio, Data Analytics, radical innovation, social media, Market Research, manhattan, pharmaceutical branding, Bioarbitrage, Physician EMR, Strategy, charlotte, Predictive Analytics, venture fund, mobile technology, crowd sourcing, radical ideation, Big Data Research, naming, Information Technology, corporate development director, predictive marketing, social media marketing, payer, technology, The Need for Speed, devices, corporate identity, Africa, space, manhatta, satisfaction, divestitures, mergers and acquisitions, healthcare, wellness, medical device firms, inside sales, growth, Global, medtronic, ecosystem, future, brand name development, innovation, Hayes, sales, jobs, Twitter, identity, leaders, adjacent marketing, PESTEL, Oracle, public relations, invest, Ontology, Facebook, budgeting, merck, positioning, Insights, EMR, Key Opinion Leader Study, Scientific Ideation, buzzterms, Brand Revival, Data Forecasting, health, life sciences, corporate, business development, rebrand, global trendspotting, marketing, functional, biotechnology, intern, equity, nanodevices, market access, market strategy, Disruptive innovation, hiring, disruptive, consumer research, netnography, bill smith, brand name, IBM, patient, whitespace research, pfizer, SAP, name development, strategic positioning, new revenue cycle, brand, whitespace innovation, wendys, consumers, Blue Ocean, Big Data, investing, innovating, market expansion, sub brand, market analysis, announcement